Douglas C Redd, MD in Atlanta, GA - Medicare

Douglas C Redd, MD is a medicare enrolled "Specialist" physician in Atlanta, Georgia. His current practice location is 5505 Peachtree Dunwoody Rd Ste 370, Atlanta, Georgia. You can reach out to his office (for appointments etc.) via phone at (770) 538-1772.

Douglas C Redd is licensed to practice in * (Not Available) (license number ) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1205824497.

Contact Information

	Douglas C Redd, MD
	5505 Peachtree Dunwoody Rd Ste 370, Atlanta, GA 30342-1713
	(770) 538-1772
	(770) 538-1773

Physician's Profile

Full Name	Douglas C Redd
Gender	Male
Speciality
Experience	Years
Location	5505 Peachtree Dunwoody Rd Ste 370, Atlanta, Georgia
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Douglas C Redd attended and graduated from in

NPI Data:

NPI Number: 1205824497
Provider Enumeration Date: 10/11/2005
Last Update Date: 07/21/2022

Medicare PECOS Information:

PECOS PAC ID:
Enrollment ID:

Medical Identifiers

Medical identifiers for Douglas C Redd such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1205824497	NPI	-	NPPES
000755972Q	Medicaid	GA
1609510	Other	GA	CIGNA
CA9328	Other	GA	MEDICARE-DMERC GROUP
000755972L	Medicaid	GA
1460074	Other	GA	COVENTRY

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
2085R0204X	Radiology - Vascular & Interventional Radiology	32463 (Georgia)	Secondary
174400000X	Specialist	(* (Not Available))	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Douglas C Redd is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Douglas C Redd, MD 5505 Peachtree Dunwoody Rd Ste 370, Atlanta, GA 30342-1713 Ph: (770) 538-1772	Douglas C Redd, MD 5505 Peachtree Dunwoody Rd Ste 370, Atlanta, GA 30342-1713 Ph: (770) 538-1772

News Archive

Premier healthcare alliance expert's efforts to enhance patient safety receives recognition from DoD

The United States Department of Defense (DoD) has recognized a Premier healthcare alliance expert for his efforts to enhance patient safety while reducing healthcare costs.

Scientists discover stem cell clue to lung cancer development

Cancer Research UK scientists have revealed that stem cells become 'activated' in severely damaged lungs and help to repair them, according to a study published in the Proceeding of the National Academy of Sciences today (Monday).

Registration open for idiopathic pulmonary fibrosis healthcare summit

The Pulmonary Fibrosis Foundation (PFF) announced today that registration is now open for the IPF Summit 2011: From Bench to Bedside. The conference will feature an innovative two-day continuing medical education (CME) program for physicians, researchers, and other health care professionals. Additionally there will be a separate one-day patient, family member, and caregiver program to address the growing educational needs of the idiopathic pulmonary fibrosis (IPF) community.

CMAJ study summarizes risk factors for severe outcome among patients admitted to hospital with H1N1

A new study in CMAJ (Canadian Medical Association Journal) http://www.cmaj.ca/cgi/doi/10.1503/cmaj.091823 of all patients in Canada admitted to hospital for H1N1 in the first five months of the outbreak summarizes the risk factors for a severe outcome (www.cmaj.ca). The H1N1 pandemic presents important learnings for clinicians and researchers and data on severe outcomes can help inform future treatment and prevention guidelines.

Mylan confirms generic Generess Fe patent challenge

Mylan Inc. today confirmed that it and Famy Care Ltd. have been sued by Warner Chilcott Company LLP, in connection with the filing of an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) for Norethindrone and Ethinyl Estradiol Chewable Tablets, 0.8 mg/0.025 mg and Ferrous Fumarate Chewable Tablets. This product is the generic version of Generess Fe, a 28-day regimen indicated for use by women to prevent pregnancy.

Douglas C Redd, MD - Medicare in Atlanta, GA